Clinical Endpoints

Scottsdale, Arizona 85258

2 studies enrolling now · 8 studies all time

What they study most

Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis, Alzheimer's Disease With Vascular Pathology, Early Alzheimers Disease, Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis

Studies at this site

• Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease — Recruiting now
• A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy — Recruiting now
• A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD — Running, not enrolling
• A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease — Running, not enrolling
• Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease — Stopped early
• Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice — Stopped early
• A Study of the Effects of CY6463 in Participants With Alzheimer's Disease With Vascular Pathology — Stopped early
• A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD — Completed